Books on the topic 'New antibiotics'

1948-, Priebe Waldemar, and American Chemical Society. Division of Carbohydrate Chemistry., eds. Anthracycline antibiotics: New analogues, methods of delivery, and mechanisms of action. Washington, DC: American Chemical Society, 1995.

P, Rosen Barry, Mobashery Shahriar, and Symposium on Resolving the Antibiotic Paradox: Progress in Drug Design and Resistance (1997 : Wayne State University), eds. Resolving the antibiotic paradox: Progress in understanding drug resistance and development of new antibiotics. New York: Kluwer Academic/Plenum, 1998.

N, Chakrabarty A., and National Institute of Science Communication (New Delhi, India), eds. Non antibiotics: A new class of unrecognised antimicrobics. New Delhi: National Institute of Science Communication, 1998.

Center for Drugs and Biologics (U.S.). Guideline on formatting, assembling, and submitting new drug and antibiotic applications. Rockville, Md: Center for Drugs and Biologics, Food and Drug Administration, Department of Health and Human Services, 1987.

1934-, Neu Harold C., Young Lowell S, and Zinner Stephen H. 1939-, eds. The New macrolides, azalides, and streptogramins: Pharmacology and clinical applications. New York: M. Dekker, 1993.

1939-, Zinner Stephen H., and ICMASK (4th : 1998 : Barcelona, Spain), eds. New considerations for macrolides, azalides, streptogramins, and ketolides. New York: Marcel Dekker, 2000.

Gray, Lynn. Antibiotic resistance: New products and strategies. Norwalk, CT: Business Communications Co., 2002.

Bellido, F. The new -lactams: Mode of action, mechanisms of resistance. Basle, Switzerland: Roche, 1989.

1939-, Zinner Stephen H., and International Conference on the Macrolides, Azalides, and Streptogramins (3rd : 1996 : Lisbon, Portugal), eds. Expanding indications for the new macrolides, azalides, and streptogramins. New York: Dekker, 1997.

NATO, Advanced Research Workshop on a. New Model for Analyzing Antimicrobial Peptides with Biomedical Applications (2001 Prague Czech Republic). A new model for analyzing antimicrobial peptides with biomedical applications. Amsterdam: IOS Press, 2002.

Champney, W. Scott, ed. New Antibiotic Targets. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-246-5.

Scott, Champney W., ed. New antibiotic targets. Totowa, N.J: Humana Press, 2008.

International IMVI Essen/WHO Symposium. (2nd 1988 Essen, Germany). Progress in rabies control: Proceedings of the Second International IMVI ESSEN/WHO Symposium on "New Developments in Rabies Control", Essen, 5-7 July 1988 ; and, Report of the WHO Consultation on Rabies, Essen, 8 July 1988. Edited by Thraenhart Olaf, Universität Essen. Institute for Medical Virology and Immunology., World Health Organization, and WHO Consultation on Rabies. (1988 : Essen, Germany). Royal Tunbridge Wells, Kent: Wells Medical, 1989.

A, Fisher Jeffrey. The plague makers: How we are creating catastrophic new epidemics-- and what we must do to avert them. New York: Simon & Schuster, 1994.

Emerging epidemics: The menance of new infections. New York, N.Y: Penguin Books, 2010.

A fierce radiance: A novel. New York: Harper, 2010.

Office, General Accounting. Food safety: New initiatives would fundamentally alter the existing system : report to Congressional requesters. Washington, D.C: U.S. General Accounting Office, 1996.

Center for Drugs and Biologics (U.S.), ed. Guideline on formatting, assembling, and submitting new drug and antibiotic applications. Rockville, Md: Center for Drugs and Biologics, Food and Drug Administration, Dept. of Health and Human Services, 1987.

Center for Drugs and Biologics (U.S.), ed. Guideline for the format and content of the summary for new drug and antibiotic applications. Rockville, Md: Center for Drugs and Biologics, Food and Drug Administration, Dept. of Health and Human Services, 1987.

Olisa, Nzedegwu Robert. Biological agents index: Quality management of infectious disease intervention programs : achieving cost-effective outcomes using macroeconomics and microbiology, in additions to new public management concepts for implementation and evaluation of best practices in community based sanitation, health promotion, large scale antibiotics and vaccines manufacturing, and laboratory analytical platforms. 3rd ed. El Paso, Tex: American Journal of Biological Defense Press, 2008.

R, Kiani, Shimada K, and International Congress of Chemotherapy (15th : 1987 : Istanbul, Turkey), eds. New oral cephalosporin antibiotic--cefixime: Workshop, 15th International Congress of Chemotherapy, July 19-24, 1987, Istanbul, Turkey. Landsberg/Lech: Ecomed, 1988.

F, Acar J., and Neu Harold C. 1934-, eds. Roxithromycin: A new antibiotic : posters presented at a symposium held in Paris, 29-30th May 1987, sponsored by Roussel Uclaf. London: Medical Tribune Group, 1988.

Harvey, Arbit, and United States. Department of Health and Human Services., eds. Keyword guide to applications for FDA approval to market a new drug (NDA) or an antibiotic drug (21CFR-part 314). Prairie View (Ill.): Interpharm Press, 1987.

Bedford, Michael R., Gary G. Partridge, Milan Hruby, and Carrie L. Walk, eds. Enzymes in farm animal nutrition. 3rd ed. Wallingford: CABI, 2022. http://dx.doi.org/10.1079/9781789241563.0000.

Mills, Lester S. Synthetic approaches to the antitumour-antibiotic CC-1065: Application of a new phase transfer catalyst to oxidation : investigation of an unexpected reaction of methoxyacetyl chloride. Norwich: University of East Anglia, 1985.

Franceschi, G., and S. Mitsuhashi. New Penem Antibiotics. Springer-Verlag Berlin and Heidelberg GmbH & Co. KG, 1991.

Wilson, Mary E. Antibiotics. Oxford University Press, 2019. http://dx.doi.org/10.1093/wentk/9780190663414.001.0001.

Hall, James, and Allen Turner. Antibiotic Therapy: New Developments. Nova Science Publishers, Incorporated, 2013.

Chemical analysis for antibiotics used in agriculture: New methodology for antibiotic residue determination. Arlington, VA: AOAC international, 1995.

Rosen, Barry P. Resolving the Antibiotic Paradox: Progress in Understanding Drug Resistance and Development of New Antibiotics. Springer, 2012.

Mobashery, Shahriar, and Barry P. Rosen. Resolving the Antibiotic Paradox: Progress in Understanding Drug Resistance and Development of New Antibiotics. Springer London, Limited, 2012.

Firestine, Steven M., Troy Lister, Christian Melander, Ernesto Abel-Santos, and Cezar Khursigara. Antibiotic Drug Discovery: New Targets and Molecular Entities. Royal Society of Chemistry, The, 2017.

The Search Of New Generations Of Antibiotics: Concern for bacterial resistance in humans. Suggesting a shift in strategy-. Wiesbaden, Germany: Progress International Verlag, 1999.

Anthracycline Antibiotics in Cancer Therapy: Proceedings of the International Symposium on Anthracycline Antibiotics in Cancer Therapy, New York, New York, 16-18 September 1981. Springer Netherlands, 2012.

Anthracycline Antibiotics in Cancer Therapy: Proceedings of the International Symposium on Anthracycline Antibiotics in Cancer Therapy, New York, New York, 16-18 September 1981. Springer, 2012.

Muggia, Franco M., Charles W. Young, and Stephen K. Carter. Anthracycline Antibiotics in Cancer Therapy: Proceedings of the International Symposium on Anthracycline Antibiotics in Cancer Therapy, New York, New York, 16-18 September 1981. Springer, 2012.

Felgueiras, Helena, ed. New Biomolecules and Drug Delivery Systems as Alternatives to Conventional Antibiotics. MDPI, 2022. http://dx.doi.org/10.3390/books978-3-0365-4735-0.

Pseudomonas Aeruginosa: New Therapeutic Approaches from Basic Research (Antibiotics and Chemotherapy). S. Karger AG (Switzerland), 1985.

(Editor), Barry P. Rosen, and Shahriar Mobashery (Editor), eds. Resolving the Antibiotic Paradox: Progress in Understanding Drug Resistance and Development of New Antibiotics (Advances in Experimental Medicine and Biology). Springer, 1999.

Klein, Eili Y. Antibiotic Resistance. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199976805.003.0068.

Hopkins, Susan. The international and national challenges faced in ensuring prudent use of antibiotics. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198758792.003.0001.

1934-, Neu Harold C., and International Conference on the Macrolides, Azalides, and Streptogramins (2nd : 1994 : Venice, Italy), eds. New macrolides, azalides, and streptogramins in clinical practice. New York: M. Dekker, 1995.

Priebe, Waldemar. Anthracycline Antibiotics: New Analogues, Methods of Delivery, and Mechanisms of Action (Acs Symposium Series). Oxford University Press, USA, 1995.

European infectious and sexually transmitted disease diagnostic product markets: Emergence of significant new products entices new vendors. Mountain View, CA: Frost & Sullivan, 1994.

Ruan, Zhi, Ye Feng, Yi-Wei Tang, Shaolin Wang, and Anne-Catrin Uhlemann, eds. New Insights Into the Transmission Dynamics and Control of Antimicrobial Resistance to Last-resort Antibiotics. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88974-883-9.

Czech Republic) NATO Advanced Research Workshop on a New Model for Analyzing Antimicrobial Peptides with Biomedical Applications (2001 : Prague, Alain Beschin, and Martin Bilej. A New Model for Analyzing Antimicrobial Peptides With Biomedical Applications (Nato: Life and Behavioural Sciences, 343). Ios Pr Inc, 2002.

Goffin, Eric, Laura Labriola, and Michel Jadoul. Bacterial and fungal infections in patients on peritoneal dialysis. Edited by Jonathan Himmelfarb. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0270.

Champney, W. Scott. New Antibiotic Targets. Humana Press, 2010.

Simmonds, Nicholas, and Elaine Dhouieb. Management of stable CF lung disease. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780198702948.003.0004.

Chastre, Jean. Diagnosis and management of nosocomial pneumonia. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0117.